Current Management and Unmet Needs in Alopecia Areata: Viewpoint From a Malaysian Perspective - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Management Strategies and Existing Gaps in Alopecia Areata: Insights from Malaysia

  • By

  • Azura Mohd Affandi

  • Adawiyah Jamil

  • Noor Zalmy Azizan

  • Felix Boon-Bin Yap

  • Kin Fon Leong

  • Agnes Yoke Hui Heng

  • Siti Nuraihan

  • Wooi Chiang Tan

  • Latha Selvarajah

  • Teeba Raja

  • Evelyn Wen Yee Yap

  • Peter Wee Beng Ch'ng

  • Tze Yuen Teoh

  • Mei Ying Tey

  • September 21, 2026

Share

  • 1

    Alopecia areata (AA) is a chronic autoimmune disorder causing nonscarring hair loss, affecting approximately 1 in 1000 individuals.

  • 2

    AA commonly coexists with comorbidities such as vitiligo, lupus, and thyroid disorders, increasing the risk of other autoimmune conditions.

  • 3

    The onset of AA typically occurs around 30 years of age, with significant risk factors for severe disease including male sex and prolonged duration.

  • 4

    In Malaysia, initial AA management often occurs in primary care settings, with referrals to dermatology for uncertain diagnoses or inadequate treatment.

  • 5

    Malaysia faces gaps in epidemiological data and clinical guidelines for AA, impacting the quality of care and health outcomes for affected patients.

Original Source(s)

Related Content